On December 12, 2023, Madryn Asset Management, LP issued an open letter to fellow shareholders regarding its opposition to SomaLogic, Inc.?s proposed merger with Standard BioTools Inc. Madryn Asset Management also announced that it has filed a preliminary proxy statement with the Securities and Exchange Commission in order to solicit proxies in opposition to the Merger. Madryn Asset Management added that it urges shareholders to wait to receive its definitive proxy statement and Madryn Asset Management?s proxy card in the mail prior to determining how to vote at the special meeting of stockholders slated for January 4, 2024.